Statements (122)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
Health information system |
| gptkbp:administeredBy |
adults
children injection |
| gptkbp:alsoKnownAs |
gptkb:IIS
gptkb:rVSV-ZEBOV Immunization information system |
| gptkbp:alternativeName |
COVID-19_vaccine
Ebola_vaccine Immunization_registry Vaccine conjugate_vaccine inactivated_vaccine mRNA_vaccine pneumococcal_conjugate_vaccine vaccination vaccination_campaign vaccine_adjuvant 疫苗 |
| gptkbp:approvedBy |
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency gptkb:U.S._Food_and_Drug_Administration 2000 2019 |
| gptkbp:ATCCode |
gptkb:J07AL
|
| gptkbp:benefit |
Facilitate school entry requirements
Identify under-vaccinated populations Prevent over-vaccination Support outbreak response |
| gptkbp:brand |
gptkb:Ervebo
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:category |
live attenuated vaccine
|
| gptkbp:challenge |
Interoperability
Privacy concerns Data accuracy Data completeness |
| gptkbp:clinicalTrialPhase |
gptkb:Guinea
gptkb:Liberia gptkb:Sierra_Leone |
| gptkbp:contains |
amino acid transporter
pneumococcal polysaccharides |
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:Canada gptkb:India gptkb:United_Kingdom gptkb:United_States |
| gptkbp:dataCollected |
Manufacturer
Patient demographics Date of vaccination Vaccine type Provider information Lot number |
| gptkbp:dataPrivacyConcern |
Data security
Patient confidentiality |
| gptkbp:dataRetention |
Varies by jurisdiction
Often retained for lifetime |
| gptkbp:dataSource |
Authorized users
|
| gptkbp:developedBy |
gptkb:Pfizer
gptkb:Merck GlaxoSmithKline |
| gptkbp:dosingRegimen |
single dose
|
| gptkbp:example |
gptkb:PCV13
gptkb:Australian_Immunisation_Register gptkb:PCV10 gptkb:PCV15 gptkb:PCV20 gptkb:PCV7 CANImmunize CDC Immunization Information Systems (IIS) NHS Immunisation Management Service |
| gptkbp:includedIn |
gptkb:WHO_Essential_Medicines_List
|
| gptkbp:indication |
gptkb:Zaire_ebolavirus
|
| gptkbp:prevention |
gptkb:pneumonia
meningitis pneumococcal disease bacteremia Streptococcus pneumoniae infection |
| gptkbp:purpose |
Improve public health
Track vaccination records |
| gptkbp:recommendation |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization |
| gptkbp:reduces |
antibiotic resistance
hospitalizations pneumococcal carriage |
| gptkbp:regulates |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization gptkb:Public_Health_Agency_of_Canada State health departments |
| gptkbp:relatedTo |
gptkb:Vaccination
gptkb:Ebola_virus_disease_outbreak_2014–2016 public health emergency response Disease prevention Public health surveillance Electronic health record Vaccine-preventable diseases |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue headache muscle pain injection site pain irritability |
| gptkbp:storage |
-80°C to -60°C
|
| gptkbp:target |
gptkb:Ebola_virus
|
| gptkbp:technology |
Interoperability standards
Electronic health records integration Web-based portals |
| gptkbp:type |
vaccine
recombinant vesicular stomatitis virus-based vaccine |
| gptkbp:updated |
Healthcare providers
Public health officials |
| gptkbp:usedBy |
Schools
Healthcare providers Patients Public health agencies |
| gptkbp:usedFor |
prevention of Ebola virus disease
|
| gptkbp:usedIn |
immunization schedule
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:WHOPrequalified |
2019
|
| gptkbp:bfsParent |
gptkb:Anthrax
|
| gptkbp:bfsLayer |
3
|